Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
These results suggest that CHM-f nanoparticle with or without CpG IAMA-002 is a promising candidate as a universal influenza vaccine.
Authors
- De Yang (ORCID: https://orcid.org/0000-0001-6705-8504)
- Jia Liu (ORCID: https://orcid.org/0000-0001-8424-7972)
- Bo Wang (ORCID: https://orcid.org/0000-0002-1422-8917)
- Li Liu (ORCID: https://orcid.org/0000-0003-3022-936X)
- Jingyu Wang (ORCID: https://orcid.org/0000-0003-0433-9549)
- Shuangshuang Guo
- Yating Wang (ORCID: https://orcid.org/0000-0002-2030-6176)
- Enqi Du (ORCID: https://orcid.org/0000-0002-2970-7232)
- Chun Peng (ORCID: https://orcid.org/0000-0001-8759-6190)
- Qi Pan (ORCID: https://orcid.org/0000-0001-6580-2731)
- Yongqiang Zhao
- Haïwen Tang
- S. Li (ORCID: https://orcid.org/0009-0004-4346-7396)
- Longping Chen
Institutions
- Northwest A&F University (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1186/s12951-025-03122-6
- Citations
- 6
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.13